Labetalol Hydrochloride Injection, Solution
Product Images NDC 70121-2428

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Labetalol Hydrochloride (NDC 70121-2428). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amneal Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1 (Labetalol Hydrochloride Injection Pfs 1)

Chemical structure of labetalol hydrochloride, depicting its molecular arrangement with phenyl, hydroxy, amide, and hydrochloride components as seen in the diagram.*

FDA Label Image

2 (Labetalol Hydrochloride Injection Pfs 2)

An instructional illustration showing the method to withdraw labetalol hydrochloride injection solution from a vial with a syringe. It includes a diagram labeling parts of the vial cap for removal steps, indicating proper technique.*

FDA Label Image

3 (Labetalol Hydrochloride Injection Pfs 3)

An instructional diagram depicting two hands assembling components of a syringe and vial system for labetalol hydrochloride injection. The left side shows one hand holding a vial and the other attaching a syringe needle upward. The right side illustrates parts A, B, and C of an injection cap or stopper for intravenous solution preparation.*

FDA Label Image

03 (Labetalol Hydrochloride Injection Pfs 4)

An instructional illustration showing a hand holding a syringe containing a solution, with an arrow indicating the direction of injection, likely demonstrating the administration technique for the intravenous injection of Labetalol Hydrochloride.*

FDA Label Image

04 (Labetalol Hydrochloride Injection Pfs 5)

An instructional illustration labeled 'Figure 4' showing a hand holding a syringe with a plunger being pulled back, indicated by an arrow pointing upward. It visually demonstrates the action of drawing up or preparing an injection solution.*

FDA Label Image

10 (Labetalol Hydrochloride Injection Pfs 6)

Label for Labetalol Hydrochloride Injection USP in a 4 mL single-dose syringe with a concentration of 5 mg/mL (total 20 mg/4 mL). The label indicates intravenous use only, storage instructions, and distributor Amneal Pharmaceuticals LLC. It includes lot and expiration date placeholders and a bar code.*

FDA Label Image

11 (Labetalol Hydrochloride Injection Pfs 7)

The packaging label for Labetalol Hydrochloride Injection, USP, shows a 20 mg per 4 mL (5 mg/mL) intravenous injection. It is a 4 mL single-dose syringe with needle not included, distributed by Amneal Pharmaceuticals LLC. The label includes storage instructions and a note that it is Rx only.*

FDA Label Image

12 (Labetalol Hydrochloride Injection Pfs 8)

Label for Labetalol Hydrochloride Injection, USP, showing 20 mg per 4 mL (5 mg/mL) concentration. It is for intravenous injection, single-dose syringes without needles, with a package count of 24 x 4 mL. Manufactured by Amneal Pharmaceuticals Pvt. Ltd. and distributed by Amneal Pharmaceuticals LLC. Includes storage instructions and preservative details.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.